Surface Oncology Profit Margin

Surface Oncology (SURF) currently reports a profit margin of -313.36% as of June 2023. That compares with -208.03% in the prior-year period — down 50.6% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Surface Oncology's profit margin history and peer comparisons.

Surface Oncology's profit margin decreased from -208.03% to -313.36% — a 50.6% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Surface Oncology's profit margin of -313.36% is lower than the Healthcare sector average of 13.89%. That is roughly 2355.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Surface Oncology's current -313.36% should be judged against Healthcare norms (sector average: 13.89%) and against SURF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -313.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Surface Oncology, and consider following SURF for alerts when major investors trade the stock.